International Clinical Trial: Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk Stratification and Post-Treatment Surveillance in Fresh Thyroid Cancer Patients

Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07532356) titled 'Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk Stratification and Post-Treatment Surveillance in Fresh Thyroid Cancer Patients' on April 8.

Study Type: Observational [Patient Registry]

Primary Sponsor: National Taiwan University Hospital

Condition: Genomics Thyroid Cancer NGS

Recruitment Status: Not recruiting

Date of First Enrollment: August 1, 2026

Target Sample Size: 100

To know more, visit https://clinicaltrials.gov/study/NCT07532356

Disclaimer: Curated by HT Syndication....